Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Obstet Gynaecol Res ; 38(1): 65-9, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21827579

ABSTRACT

AIM: To investigate the value of tetracycline sclerotherapy for management of recurrent or persisting non-neoplastic ovarian cysts in comparison to the aspiration without sclerotherapy. MATERIAL AND METHODS: Ninety-six patients with proven non-neoplastic ovarian cysts were randomized into two groups. Group 1 patients underwent cyst aspiration together with tetracycline sclerotherapy (n=48). Group 2 patients underwent only cyst aspiration without tetracycline sclerotherapy (n=48). Then, all patients were followed up monthly with ultrasonography for 12months. The procedure was considered to have failed if the recurring cyst, detected by ultrasound, was 4cm in size or greater. RESULTS: There were no differences between the two groups regarding demographic data, initial cyst volume and tumor markers. Recurrence rates within 12months were 14.6% in group 1 and 50% in group 2 (P<0.001). CONCLUSION: Based on the recurrence rates, we suggest transvaginal aspiration together with tetracycline sclerotherapy rather than only simple transvaginal aspiration in the management of non-neoplastic ovarian cysts.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Ovarian Cysts/therapy , Ovary/diagnostic imaging , Sclerotherapy/methods , Suction , Tetracycline/therapeutic use , Female , Humans , Middle Aged , Ovarian Cysts/diagnostic imaging , Ovarian Cysts/surgery , Recurrence , Treatment Outcome , Ultrasonography
2.
Int J Gynaecol Obstet ; 106(3): 250-3, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19428005

ABSTRACT

OBJECTIVE: To compare the efficacy of vaginal versus sublingual misoprostol for second-trimester pregnancy termination, and to evaluate the effect on the blood flow of the uterine and umbilical arteries. METHODS: Forty-nine patients were randomized to receive either 200 microg of vaginal misoprostol every 6 hours or 200 microg of misoprostol sublingually every 6 hours. Doppler velocimetry studies were assessed immediately before and 60 minutes after the administration of the first dose. Standard descriptive calculations, Mann-Whitney U, Wilcoxon, and chi(2) tests were performed. RESULTS: The mean interval between induction and onset of active labor, induction and delivery, and the duration of oxytocin administration were significantly shorter in the sublingual misoprostol group. Both routes of administration increased the Doppler indices for the uterine arteries; however, misoprostol via the sublingual route did not affect the umbilical arteries. CONCLUSION: Sublingual administration of misoprostol for second-trimester medical abortion results in a higher success rate and does not affect umbilical blood flow.


Subject(s)
Abortifacient Agents, Nonsteroidal/administration & dosage , Abortion, Induced/methods , Misoprostol , Umbilical Arteries/drug effects , Uterus/blood supply , Administration, Intravaginal , Administration, Sublingual , Blood Flow Velocity/drug effects , Female , Humans , Laser-Doppler Flowmetry , Misoprostol/administration & dosage , Pregnancy , Pregnancy Trimester, Second , Regional Blood Flow/drug effects , Treatment Outcome , Ultrasonography , Umbilical Arteries/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...